These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6188832)

  • 1. A highly discriminatory multi-typing scheme for Proteus mirabilis and Proteus vulgaris.
    Senior BW; Larsson P
    J Med Microbiol; 1983 May; 16(2):193-202. PubMed ID: 6188832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proticine typing of serologically defined Proteus strains.
    Csiszár K; Lányi B
    Acta Microbiol Acad Sci Hung; 1981; 28(1):111-8. PubMed ID: 7020353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typing of Proteus strains by proticine production and sensitivity.
    Senior BW
    J Med Microbiol; 1977 Feb; 10(1):7-17. PubMed ID: 320341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
    Sekaninová G; Kolárová M
    Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dienes phenomenon: identification of the determinants of compatibility.
    Senior BW
    J Gen Microbiol; 1977 Oct; 102(2):235-44. PubMed ID: 925679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the usefulness of standard strains sets from the senior collection for typing Proteus mirabilis strains].
    Aleksandrowicz I; Samet A
    Med Dosw Mikrobiol; 1994; 46(4):285-91. PubMed ID: 7603129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and serological classification of O-specific polysaccharide of Proteus mirabilisTG 276-90 from Proteus serogroup O34.
    Kołodziejska K; Siwińska M; Zych K; Rózalski A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):223-6. PubMed ID: 16736109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O antigens of Proteus mirabilis and Proteus vulgaris strains isolated from patients with bacteremia.
    Larsson P
    J Clin Microbiol; 1980 Oct; 12(4):490-2. PubMed ID: 6999017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of a Proteus mirabilis strain to invade the bloodstream is independent of its proticine production/proticine sensitivity type.
    Senior BW
    J Med Microbiol; 1997 May; 46(5):407-12. PubMed ID: 9152037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1980 Sep; 12(3):304-9. PubMed ID: 7012166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic sensitivity and proticine typing of Proteus mirabilis strains associated with rheumatoid arthritis.
    Wilson C; Senior BW; Tiwana H; Caparros-Wanderley W; Ebringer A
    Rheumatol Int; 1998; 17(5):203-5. PubMed ID: 9542782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of particular types of Proteus with chronic suppurative otitis media.
    Senior BW; Sweeney G
    J Med Microbiol; 1984 Apr; 17(2):201-5. PubMed ID: 6368831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of hospital strains of Proteus mirabilis by the methods of proticine and bacteriophage typing].
    Zawieja M
    Med Dosw Mikrobiol; 1988; 40(4):213-8. PubMed ID: 3073282
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacteriocine typing of Proteus.
    Al-Jumaili IJ
    J Clin Pathol; 1975 Oct; 28(10):784-7. PubMed ID: 765360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteus-typing by proticin production and susceptibility.
    Bongaerts GP; Bruggeman-Ogle KM; de Raad Slootweg JM; Mouton RP
    Antonie Van Leeuwenhoek; 1981; 47(6):525-38. PubMed ID: 7039501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures and serology of the O-antigens of Proteus strains classified into serogroup O17 and former serogroup O35.
    Torzewska A; Grabowski S; Kondakova AN; Toukach FV; Senchenkova SN; Shashkov AS; Arbatsky NP; Knirel YA; Rózalski A; Kaca W
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):277-82. PubMed ID: 16868723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistotyping of Proteus mirabilis and a comparison with other methods of typing.
    Kashbur IM; George RH; Ayliffe GA
    J Clin Pathol; 1974 Jul; 27(7):572-7. PubMed ID: 4138833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological classification and epitope specificity of Proteus vulgaris TG 251 from Proteus serogroup O65.
    Zych K; Kołodziejska K; Drzewiecka D; Perepelov AV; Knirel YA; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):187-91. PubMed ID: 17557147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
    Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
    Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The special affinity of particular types of Proteus mirabilis for the urinary tract.
    Senior BW
    J Med Microbiol; 1979 Feb; 12(1):1-8. PubMed ID: 372530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.